Penumbra Inc (PEN) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Penumbra reported revenue of $1.40B, up 17.5% from $1.19B the year before. Net income was $177.7M (a 12.7% net margin), or $4.52 per diluted share. Gross margin was 67.1% and operating margin was 13.5%. Operating activities generated $238.7M of cash, leaving $174.9M of free cash flow. At fiscal year end, Penumbra held $1.83B in total assets against $398.9M in total liabilities, including $186.9M of cash and equivalents.
Open the full interactive Penumbra financials → Quarterly statements, key ratios, valuation history and price charts.
Penumbra Key Stats
| Share Price | $320.01 |
|---|---|
| Market Cap | $12.66B |
| P/E Ratio | 70.8 |
| Revenue YoY Growth | +17.5% |
| 52-Week Range | $225.54 – $359.40 |
| Shares Outstanding | 39.4 million (basic, 2026 Q2) |
Penumbra Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $560.4M | $747.6M | $847.1M | $1.06B | $1.19B | $1.40B |
| Gross Profit | $338.2M | $475.4M | $535.2M | $682.6M | $755.0M | $942.4M |
| Operating Income | -$38.9M | -$7.5M | $6.1M | $73.6M | $9.3M | $189.2M |
| Pre-Tax Income | -$38.0M | -$10.5M | $3.9M | $79.7M | $20.9M | $205.1M |
| Income Tax | -$18.8M | -$13.1M | $5.9M | -$11.3M | $6.9M | $27.4M |
| Net Income | -$15.7M | $5.3M | -$2.0M | $91.0M | $14.0M | $177.7M |
| Diluted EPS | -$0.44 | $0.14 | -$0.05 | $2.32 | $0.36 | $4.52 |
Penumbra Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $354.7M | $385.4M | $374.8M | $390.0M |
| Net Income | $45.9M | $47.3M | $32.6M | $34.8M |
| Diluted EPS | $1.17 | $1.20 | $0.82 | $0.88 |
Penumbra Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $69.7M | $59.4M | $69.9M | $167.5M | $324.4M | $186.9M |
| Current Assets | $617.7M | $681.5M | $755.7M | $915.4M | $951.1M | $1.22B |
| Total Assets | $823.0M | $1.24B | $1.37B | $1.56B | $1.53B | $1.83B |
| Current Liabilities | $105.9M | $123.2M | $144.9M | $151.1M | $158.3M | $183.1M |
| Total Liabilities | $185.2M | $290.3M | $372.0M | $377.4M | $382.2M | $398.9M |
| Shareholders' Equity | $641.5M | $953.9M | $998.9M | $1.18B | $1.15B | $1.43B |
Penumbra Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$33.2M | $9.5M | -$55.7M | $97.3M | $168.5M | $238.7M |
| Cash From Investing | -$104.1M | -$21.7M | $54.8M | -$16.1M | $77.6M | -$404.6M |
| Cash From Financing | $134.9M | $836,000 | $11.6M | $16.2M | -$87.0M | $26.5M |
| Free Cash Flow | -$58.0M | -$11.7M | -$75.0M | $82.1M | $147.3M | $174.9M |
Figures from Penumbra's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Penumbra financials page for every line item.
Penumbra Company Profile
| Ticker | PEN |
|---|---|
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Alameda, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001321732 |
Frequently Asked Questions
What was Penumbra's revenue in fiscal 2025?
Penumbra (PEN) reported revenue of $1.40B for fiscal 2025.
What is Penumbra's annual revenue history?
Penumbra's annual revenue by fiscal year: 2020: $560.4M; 2021: $747.6M; 2022: $847.1M; 2023: $1.06B; 2024: $1.19B; 2025: $1.40B.
What was Penumbra's net income in fiscal 2025?
Penumbra reported net income of $177.7M for fiscal 2025.
What was Penumbra's earnings per share (EPS) in fiscal 2025?
Penumbra's diluted EPS was $4.52 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Penumbra generate in fiscal 2025?
Penumbra generated $174.9M of free cash flow in fiscal 2025.
What was Penumbra's revenue last quarter?
In its most recent reported quarter (2026 Q2), Penumbra reported revenue of $390.0M.
How many shares of Penumbra are outstanding?
Penumbra reported a weighted average of 39.4 million basic shares outstanding in 2026 Q2.
What is Penumbra's market cap?
Based on its latest closing price, Penumbra (PEN) has a market capitalization of about $12.66B.
When does Penumbra's fiscal year end?
Penumbra's fiscal year end, as registered with the SEC, is December 31.
Where is Penumbra headquartered?
Penumbra lists its business address in Alameda, California in its SEC filings.